spacer
home > pmps > summer 2002 > the cphi worldwide 2002 conference preview - where science comes first
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The CPhI Worldwide 2002 Conference Preview - Where Science Comes First

This is where the CPhI conference comes in. The two-day programme will include high profile speakers presenting papers with in-depth scientific information on pharmaceutical techniques. The best way to measure the success of an exhibition such as CPhI Worldwide is to look at the actual number of attendees. Last year's combined event hosted 8,703 individual visitors, from over 110 countries around the world. Together with the exhibitors, the CPhI event in 2001 attracted almost 18,000 industry professionals.




France - A Major Market for Pharmaceuticals

'The French fine pharmaceutical chemicals industry is responsible for an annual turnover of US$3.7 billion and creates employment for over 20,000 people. Its 58 million residents - the second largest market in Europe and fourth largest in the world - are Europe's largest per capita consumers of pharmaceutical products. When calculated as a percentage of total health spending, France spends twice as much as the US does on medicine. Total turnover for pharmaceutical products amounted to US$20 billion in 1996 (approximately US$18 billion), about a quarter of which was exported.

The French pharmaceutical industry comprises 334 pharmaceutical companies in a very fragmented market. The top 20 companies in France controlled just 53 per cent of the domestic market in 1996. France ranked third after the US and Japan in a number of new pharmaceutical product launches in 1995. In 1996, France hosted the second highest number of biotech companies in Europe and, this year, hosts the third highest (1).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Rebecca Cavalôt of PMPS
spacer
Rebecca Cavalôt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement